What is the treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo

For impetigo treatment, topical antibiotics are the first-line therapy for limited lesions, with mupirocin 2% ointment applied three times daily for 5-7 days being the recommended option. 1, 2

First-Line Treatment: Topical Antibiotics

  • Mupirocin 2% ointment should be applied to affected areas three times daily for 5-7 days for limited lesions, as recommended by the American Academy of Pediatrics and the Infectious Diseases Society of America 1
  • Retapamulin 1% ointment is an effective alternative, applied twice daily for 5 days 1, 3
  • Topical antibiotics have been shown to be more effective than placebo with better cure rates (risk ratio 2.24) 4
  • Both mupirocin and retapamulin are FDA-approved for the treatment of impetigo caused by Staphylococcus aureus and Streptococcus pyogenes 2, 3

Second-Line Treatment: Oral Antibiotics

  • Oral antibiotics are indicated when:

    • Impetigo is extensive
    • Topical therapy is impractical
    • Topical treatment has failed
    • Systemic symptoms are present 1, 5
  • First-line oral antibiotics include:

    • Dicloxacillin or first-generation cephalosporins (e.g., cephalexin) for methicillin-susceptible S. aureus (MSSA) 1, 5
    • For adults: dicloxacillin 250 mg four times daily or cephalexin 250-500 mg four times daily 5
    • Dosing should be adjusted by weight for children 5
  • Studies have shown that topical mupirocin is slightly superior to oral erythromycin (risk ratio 1.07) 4

  • Penicillin alone is not effective for impetigo as it lacks adequate coverage against S. aureus 5, 6

Special Considerations for MRSA

  • Consider empiric therapy for community-acquired MRSA (CA-MRSA) in:

    • Patients at risk for CA-MRSA infection
    • Cases with failure to respond to first-line therapy
    • Areas with high local prevalence of CA-MRSA 1
  • For suspected MRSA infections, recommended options include:

    • Trimethoprim-sulfamethoxazole
    • Clindamycin (300-450 mg three times daily for adults)
    • Doxycycline (not for children under 8 years) 1, 5

Treatment Duration and Follow-up

  • Complete the full course of prescribed antibiotics even if symptoms improve quickly to prevent complications such as post-streptococcal glomerulonephritis 1
  • Topical treatment should be used for 5-7 days, and oral antibiotics for 5-10 days 5
  • Re-evaluate if no improvement after 48-72 hours of therapy 5

Common Pitfalls and Caveats

  • Tetracyclines (doxycycline, minocycline) should not be used in children under 8 years of age 5
  • Topical disinfectants are inferior to antibiotics and should not be used 4, 7
  • Obtain cultures of the vesicle fluid, pus, or erosions if there is treatment failure, MRSA is suspected, or in cases of recurrent infections 5
  • Keep lesions covered with clean, dry bandages and maintain good personal hygiene to prevent spread, especially in close-contact settings like military or sports 5, 8
  • Worldwide, bacteria causing impetigo show growing resistance rates for commonly used antibiotics, which may influence treatment choices 4

Treatment Algorithm Summary

  1. For limited impetigo:

    • Start with topical mupirocin 2% ointment three times daily for 5-7 days 1, 2
    • Alternative: retapamulin 1% ointment twice daily for 5 days 1, 3
  2. For extensive disease or when topical therapy is impractical:

    • Use oral antibiotics active against both S. aureus and streptococci 1, 5
    • First choice: dicloxacillin or cephalexin 1
    • For suspected MRSA: clindamycin, trimethoprim-sulfamethoxazole, or doxycycline (age-appropriate) 1, 5
  3. For treatment failure:

    • Obtain cultures and adjust therapy based on susceptibility results 5
    • Consider MRSA coverage if not already provided 1, 5

References

Guideline

Treatment of Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.